Compare WEST & USBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | WEST | USBC |
|---|---|---|
| Founded | 2009 | N/A |
| Country | United States | |
| Employees | N/A | 6 |
| Industry | Beverages (Production/Distribution) | |
| Sector | Consumer Staples | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 379.6M | 317.5M |
| IPO Year | N/A | N/A |
| Metric | WEST | USBC |
|---|---|---|
| Price | $4.33 | $0.78 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $9.00 | N/A |
| AVG Volume (30 Days) | ★ 625.7K | N/A |
| Earning Date | 11-06-2025 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,078,457,000.00 | N/A |
| Revenue This Year | $40.23 | N/A |
| Revenue Next Year | $8.80 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 28.89 | N/A |
| 52 Week Low | $3.59 | N/A |
| 52 Week High | $8.29 | N/A |
| Indicator | WEST | USBC |
|---|---|---|
| Relative Strength Index (RSI) | 48.54 | 44.92 |
| Support Level | $4.00 | $0.71 |
| Resistance Level | $4.48 | $0.87 |
| Average True Range (ATR) | 0.29 | 0.08 |
| MACD | 0.05 | 0.01 |
| Stochastic Oscillator | 57.74 | 45.61 |
Westrock Coffee Co is an integrated coffee, tea, flavors, extracts, and ingredients solutions provider in the U.S, providing coffee sourcing, supply chain management, product development, roasting, packaging, and distribution services to retail, foodservice and restaurant, convenience store and travel center, non-commercial account, CPG, and hospitality industries around the world. The company's segment includes Beverage Solutions and Sustainable Sourcing and Traceability. It generates maximum revenue from the Beverage Solutions segment.
USBC Inc is a non-invasive medical diagnostics. The group is focused on the development and commercialization of proprietary sensor technology utilizing radio and microwave dielectric spectroscopy. Its Sensor technology elicits a dielectric response that is different for every molecule. The group considers the business to currently have one operating segment: the development of its radio frequency spectroscopy technology, with a first focus on non-invasively ascertaining blood glucose levels.